The Karnataka High Court has permitted eight companies to use Ashwagandha leaf in health supplements, despite a ban by the FSSAI, after they challenged the directive. This ruling may reshape health supplement formulations in India.
Karnataka High Court's Ruling on Ashwagandha Use
The Karnataka High Court has issued a stay against an advisory from the Food Safety and Standards Authority of India (FSSAI) that restricted the use of Ashwagandha leaves in health and food supplements. This significant ruling applies to eight companies that had legally contested the FSSAI's directive which only allowed the use of Ashwagandha roots and extracts.
The FSSAI's position was grounded in concerns regarding the efficacy and safety of using Ashwagandha leaves. However, the Court's decision focused on broader implications for the companies involved, allowing them to continue the use of the leaves in their products until a full hearing can be conducted.
This landmark ruling may set a precedent for other manufacturers looking to include Ashwagandha leaves in their formulations. Legal practitioners in the health supplement industry should evaluate potential impacts on product development and compliance with regulatory standards moving forward.
Citations
- Sami-Sabinsa Group Ltd & Ors v Union of India & Ors (2026)
